Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Sweden Q2 Oper Revenue Up At SEK 324,505

Aug 31 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q2 OPERATING REVENUE SEK 324,505 VERSUS SEK 53,975 YEAR
AGO
    * Q2 REVENUE SEK 324,505 VERSUS SEK 53,975 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr9Pc1Xb 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Bio Vitos Pharma AB

See all news